Historical and conceptual grounding in bioscience as an investable asset class and the role of angel investors in translating research into real-world solutions.

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

Overview of major life sciences subsectors—including agtech, medical biotech, biotools, bioindustrials, and digital health—with emphasis on market potential and risk profiles.

A structured framework for evaluating scientific validity, IP strength, regulatory feasibility, management quality, and financial readiness.

Understanding U.S. and global regulatory frameworks (FDA, USDA, EPA, EMA) and how regulatory strategy impacts timelines, costs, and investment theses.

Portfolio construction, position sizing, exit expectations, and the strategic use of tools like Kansas Angel Tax Credits and tax-loss harvesting.

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

Applying the framework in practice, engaging with KC BioHub dealflow, co-investing, shared diligence, and continued participation through investor meetups.

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.